| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 2e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 3e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.21 | 7e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |